In this study, we construct a prognosis risk model to predict the overall survival (OS) outcomes of NSCLC patients based on the expression of five hub ANKRD genes (ANKRD29, ANKRD34B, ANKRD40CL, ANKRD44 and ANKRD66). Here, ANKRD29 is linked to non-small cell lung carcinoma.